Award
NIH Reporter #11316739
Process Validation and Commercialization of SelfWrap, a Bioabsorbable Wrap to Improve Dialysis Access Outcomes
Recipient
VENOSTENT, INC.
Award Amount
$500,000.00
Ceiling
$500,000.00
Awarded
September 11, 2026
Identifier
11316739
Award for process validation and commercialization of a bioabsorbable wrap to improve dialysis access outcomes, funded by NIH with FDA Breakthrough Device Designation.
Description
The project involves process validation and commercialization activities for a bioabsorbable wrap to improve dialysis access outcomes. The funding is provided by the NIH, with a Breakthrough Device Designation from FDA in 2022. The project aims to revolutionize vascular surgery and improve patient outcomes.